Parnax Lab Ltd.
Fundamentals
- Market cap
- ₹175 cr
- P/E
- 13.94×
- ROE
- 13.86%
- Debt / equity
- 0.73
- 52-week range
- 96.25 — 182.00
The timeline — 2 notes on Parnax Lab Ltd.
May 2026
- 28 May 26 · 10:39 PM IST Brief Brief · Earnings · Micro cap
Parnax Lab revenue climbs 32% but profit stalls on rising costs
The pharma company hit ₹248.54 cr in annual revenue for FY26, yet net profit remained flat at ₹11.78 cr as operational expenses and labor-related charges weighed on the bottom line.
- 28 May 26 · 9:00 PM IST Brief Brief · Earnings · Micro cap
Parnax Lab revenue climbs 32% to ₹248.54 crore in FY26
The pharmaceutical firm grew annual sales by nearly a third, though bottom-line growth remained muted due to one-time labor code transition costs.